[HTML][HTML] Use of glucose-lowering agents in diabetes and CKD

RZ Alicic, JJ Neumiller, RJ Galindo, KR Tuttle - Kidney international reports, 2022 - Elsevier
Diabetes is the most common cause of kidney failure worldwide. Patients with diabetes and
chronic kidney disease (CKD) are also at markedly higher risk of cardiovascular disease …

Overview of atypical diabetes

J Tamaroff, M Kilberg, SE Pinney… - Endocrinology and …, 2020 - endo.theclinics.com
Although a majority of children and adults with diabetes mellitus (DM) are diagnosed with
type 1 diabetes mellitus (T1D) or type 2 diabetes mellitus (T2D), a significant number of …

RSSDI consensus recommendations on insulin therapy in the management of diabetes

R Chawla, BM Makkar, S Aggarwal, S Bajaj… - International Journal of …, 2019 - Springer
Abstract The Research Society for the Study of Diabetes in India (RSSDI) has regularly
updated its Clinical Practice Guidelines on various aspects of diabetes. The …

[HTML][HTML] Label-free mass spectrometry-based quantitative proteomics to evaluate the effects of the calcium-sensing receptor agonist cinacalcet on protein expression …

E Bulska, A Gawor, A Konopka, G Wryk… - … Medical Journal of …, 2022 - ncbi.nlm.nih.gov
Background Cinacalcet is a calcium-sensing receptor agonist that is clinically approved for
the treatment of secondary hyperparathyroidism in chronic kidney disease and …

[HTML][HTML] The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice …

JR de Sá, EB Rangel, LH Canani, AC Bauer… - Diabetology & Metabolic …, 2022 - Springer
Background Diabetic kidney disease is the leading cause of end-stage renal disease and is
associated with increased morbidity and mortality. This review is an authorized literal …

Clinical assessment and treatment of diabetes in patients with chronic kidney disease

JC Gómez, JCA Lorido - Revista Clínica Española (English Edition), 2018 - Elsevier
Diabetes mellitus type 2 is the main cause of chronic kidney disease. Patients with this
disease have higher morbidity and mortality and risk of hypoglycaemia than those without …

[HTML][HTML] Impact of kidney function on the safety and efficacy of insulin degludec versus insulin glargine U300 in people with type 2 diabetes: A post hoc analysis of the …

TR Pieber, HS Bajaj, SR Heller, T Jia… - Diabetes, Obesity & …, 2022 - ncbi.nlm.nih.gov
Chronic kidney disease (CKD) is a common complication of type 2 diabetes (T2D) that, in
insulin-treated people can result in decreased insulin clearance and increased risk of …

Pengaruh Faktor Internal dan Faktor Eksternal Obat Terhadap Keputusan Konsumen Dalam Memilih Obat Swamedikasi di Apotik S, Tangerang Selatan

Y Firmansyah, P Purwadhi, AH Rahim - Innovative: Journal Of Social …, 2024 - j-innovative.org
Swamedikasi adalah praktik di mana individu secara mandiri memilih dan menggunakan
obat-obatan tanpa resep dokter untuk mengatasi kondisi kesehatan mereka. Faktor internal …

Glycemic Control

AA Krikorian, APP Calimag - Diabetes and Kidney Disease, 2022 - Springer
The prevalence of chronic kidney disease in patients with diabetes continues to increase.
Management of these patients is quite challenging, as it needs a comprehensive and …

Basal insulin analogues in people with diabetes and chronic kidney disease

D León‐Jiménez, JP Miramontes‐González… - Diabetic …, 2022 - Wiley Online Library
Background Diabetic kidney disease is the leading cause of chronic kidney disease (CKD)
and end‐stage kidney disease (ESKD) worldwide. ESKD has a high prevalence in patients …